Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regenerative Medicine for Joint Hypermobility and Instability: A Prospective, Open-Label, Single-Arm, Step-Care Clinical Study

NCT07688096 is registered in ClinicalTrials.gov with Manhattan Pain Medicine, PLLC as lead sponsor.

NCT NCT07688096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07688096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regenerative Medicine for Joint Hypermobility and Instability: A Prospective, Open-Label, Single-Arm, Step-Care Clinical Study
Lead sponsor
Manhattan Pain Medicine, PLLC
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 15, 2027
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain syndrome, craniocervical disfunction, dislocation, ehlers-danlos syndrome (eds), ehlers-danlos syndrome hypermobility type (heds), hypermobility spectrum disorder, joint hypermobility, joint instability, musculoskeletal pain, sprain, subluxation